Skip to main content

Table 1 Clinical findings in our patient and previously reported patients with pure 11q interstitial deletion

From: Interstitial 11q deletion in a patient with Sprengel’s deformity: a case report and review of the literature

Clinical features

Number of patients in the literature*

Percentage

Present case

Neurodevelopment

Intellectual disability

19/49

39%

-

Developmental delay

22/49

45%

Mild

Speech delay

11/49

22%

-

Hypotonia

11/49

22%

-

Seizures

8/49

16%

-

Strabismus

9/49

18%

-

Growth

Intrauterine growth retardation

4/50

8%

-

Postnatal growth retardation

18/49

37%

-

Malformations

Trigonocephaly

6/49

12%

-

Dolichocephaly

3/49

6%

-

Microcephaly

5/50

10%

-

Brain anomalies (hydrocephalus, hypoplastic/absent corpus callosum, cortical atrophy, white matter abnormalities)

3/50

6%

Unexplored

Kidney/urinary tract anomalies (left renal malrotation, horseshoe kidney, bilateral duplication of ureters, vesicoureteral reflux)

6/50

12%

-

Heart anomalies (mitral valve prolapse, tricuspid insufficiency, pulmonary stenosis, double outlet right ventricle, ventricular septal defect, atrial septal defect, right atrial and ventricular enlargement, patent ductus arteriosus)

11/50

22%

-

Cleft lip/palate

11/50

22%

-

Skeletal anomalies**

16/49

33%

-

Retinal dysgenesis/exudative vitreoretinopathy

5/49

10%

-

Iris/chorioretinal coloboma

4/50

8%

+

Myopia

3/49

6%

+

Dysmorphic features

Hypertelorism

12/49

24%

+

Epi/telecanthus

9/49

18%

+

High-arched palate

16/49

33%

-

Ear anomalies

18/49

37%

+

Micro/retrognathia

15/49

31%

-

Ptosis

12/49

24%

+

  1. *Frequencies were calculated using our review of the literature (see Additional file 1). We counted patients with only pure 11q deletions (without associated genetic anomalies). We also excluded patients with unavailable information [37, 47].**Skeletal anomalies are detailed in the discussion section